We can't find the internet
Attempting to reconnect
18022.1 PFLS-LS
Structure-based drug discovery with thermostabilized G protein-coupled receptors (GPCR)
Résumé
Structure-based drug discovery with thermostabilized G protein-coupled receptors (GPCR)
Textes supplémentaires
Abstract
G protein-coupled receptors (GPCRs) are the single largest class of validated drug targets. Current|approaches in GPCR drug development led to significant failure rates and no successful novel chemical|entities (NCEs) to multiple high-value GPCR targets. G7 Therapeutics in collaboration with the University of|Zurich will apply its CHESS technology to identify and visualize the interaction of NCEs with GPCR targets of|clinical importance in order to create better medication.
Participants
Carlo Bertozzi
Wirtschaftspartner
carlo.bertozzi@g7therapeutics.com
Heptares Therapeutics Zurich AG Carlo Bertozzi Grabenstrasse 11a 8952 Schlieren ZH CH
Andreas Plückthun
Kontaktperson
plueckthun@bioc.uzh.ch
Universität Zürich Organisch-chemisches Institut Andreas Plückthun Winterthurerstrasse 190 8057 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2016-02-29
- Date de fin
- 2019-02-28
- Coûts totaux approuvés
- CHF 886937.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%